ES2029879T3 - Procedimiento para producir derivados de aminas sustituidas. - Google Patents

Procedimiento para producir derivados de aminas sustituidas.

Info

Publication number
ES2029879T3
ES2029879T3 ES198888300596T ES88300596T ES2029879T3 ES 2029879 T3 ES2029879 T3 ES 2029879T3 ES 198888300596 T ES198888300596 T ES 198888300596T ES 88300596 T ES88300596 T ES 88300596T ES 2029879 T3 ES2029879 T3 ES 2029879T3
Authority
ES
Spain
Prior art keywords
procedure
substituted amine
amine derivatives
producing substituted
refers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888300596T
Other languages
English (en)
Inventor
Susumu Tsushima
Muneo Takatani
Minoru Hirata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2029879T3 publication Critical patent/ES2029879T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Abstract

LA INVENCION SE REFIERE A AMINODERIVADOS SUSTITUIDOS, REPRESENTADOS POR LA FORMULA (I) EN LA QUE R1 Y R2, R3 Y R4, A, X1 Y X2, Y, TIENEN EL SIGNIFICADO QUE SE INDICA EN LA DESCRIPCION. TAMBIEN SE REFIERE LA INVENCION A LAS SALES DE ESTOS COMPUESTOS LOS AUCLES TIENEN ACTIVIDAD ANTI-ARRITMICA Y SON UTILES PARA LA PREVENCION Y TRATAMIENTO DE UNA DIVERSIDAD DE ARRITMIAS.
ES198888300596T 1987-02-06 1988-01-26 Procedimiento para producir derivados de aminas sustituidas. Expired - Lifetime ES2029879T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2681687 1987-02-06
JP32251087 1987-12-18
JP62331568A JPH0761992B2 (ja) 1987-02-06 1987-12-25 置換アミン誘導体

Publications (1)

Publication Number Publication Date
ES2029879T3 true ES2029879T3 (es) 1992-10-01

Family

ID=27285549

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888300596T Expired - Lifetime ES2029879T3 (es) 1987-02-06 1988-01-26 Procedimiento para producir derivados de aminas sustituidas.

Country Status (13)

Country Link
US (1) US4987130A (es)
EP (1) EP0278621B1 (es)
JP (1) JPH0761992B2 (es)
AU (1) AU607180B2 (es)
CA (1) CA1327969C (es)
DE (1) DE3863191D1 (es)
DK (1) DK45188A (es)
ES (1) ES2029879T3 (es)
FI (1) FI89907C (es)
GR (1) GR3002298T3 (es)
HU (1) HU201907B (es)
IL (1) IL85183A0 (es)
NO (1) NO167734C (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal
EP0474411A1 (en) * 1990-09-03 1992-03-11 Takeda Chemical Industries, Ltd. Production of diethanolamine derivatives and their intermediates
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
AU775925B2 (en) * 1998-12-09 2004-08-19 La Jolla Pharmaceutical Company Molecular scaffolds acting as templates comprising carbamate linkages
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
CA2414076A1 (en) * 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
JP4882146B2 (ja) * 2000-11-09 2012-02-22 Ｊｎｃ株式会社 イミド化合物、これを含有する樹脂組成物、液晶配向膜、液晶組成物および液晶表示素子
CN113773229B (zh) * 2021-09-03 2022-10-25 西安交通大学 α,β-不饱和氨基酸衍生物及其DL-硒-甲基硒代氨基酸衍生物、合成方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE949947C (de) * 1953-03-04 1956-09-27 Hoechst Ag Verfahren zur Herstellung von basischen Bis-N-phenylurethanen
CH361567A (fr) * 1959-06-11 1962-04-30 Carter Prod Inc Procédé de préparation de dicarbamates
US3285960A (en) * 1964-01-14 1966-11-15 Cutter Lab 4, 4-diphenylcyclohexylamine derivatives
CH496675A (fr) * 1968-10-29 1970-09-30 Lepetit Spa Procédé de préparation de dérivés d'acide carbamique
GB1369247A (en) * 1970-08-07 1974-10-02 Pfizer Amines the preparation thereof and their use in pharmaceutical compositions
ATE41655T1 (de) * 1985-04-16 1989-04-15 Hoffmann La Roche Phenaethanolaminderivate.

Also Published As

Publication number Publication date
NO880511D0 (no) 1988-02-05
NO167734B (no) 1991-08-26
FI89907B (fi) 1993-08-31
NO167734C (no) 1991-12-04
DK45188A (da) 1988-08-07
EP0278621B1 (en) 1991-06-12
EP0278621A1 (en) 1988-08-17
HU201907B (en) 1991-01-28
CA1327969C (en) 1994-03-22
AU607180B2 (en) 1991-02-28
FI880525A0 (fi) 1988-02-05
DK45188D0 (da) 1988-01-29
IL85183A0 (en) 1988-07-31
DE3863191D1 (de) 1991-07-18
JPH0761992B2 (ja) 1995-07-05
US4987130A (en) 1991-01-22
JPH0222259A (ja) 1990-01-25
GR3002298T3 (en) 1992-12-30
HUT45968A (en) 1988-09-28
FI880525A (fi) 1988-08-07
NO880511L (no) 1988-08-08
AU1136088A (en) 1988-08-11
FI89907C (fi) 1993-12-10

Similar Documents

Publication Publication Date Title
ES2043617T3 (es) Un procedimiento para preparar derviados de benzamida.
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
GT199800180A (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2184070T3 (es) Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina.
ES2161290T3 (es) Derivados de quinazolina.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
UY26872A1 (es) Derivados de la 4- fenil piridina
ES2097872T3 (es) Fenilpirazolidinonas como agentes broncodilatadores y antiinflamatorios.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2213732T3 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2059804T3 (es) Procedimiento de preparacion de eteres de oxima de propenona.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
PA8589801A1 (es) Aminoalcoxiindoles
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 278621

Country of ref document: ES